Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28255
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Holmes P.W. | en |
dc.contributor.author | King P.T. | en |
dc.date.accessioned | 2021-05-14T09:30:53Z | en |
dc.date.available | 2021-05-14T09:30:53Z | en |
dc.date.copyright | 2012 | en |
dc.date.created | 20120301 | en |
dc.date.issued | 2012-03-01 | en |
dc.identifier.citation | Reviews on Recent Clinical Trials. 7 (1) (pp 24-30), 2012. Date of Publication: February 2012. | en |
dc.identifier.issn | 1574-8871 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/28255 | en |
dc.description.abstract | Bronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary. © 2011 Bentham Science Publishers. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Bentham Science Publishers B.V. (P.O. Box 294, Bussum 1400 AG, Netherlands) | en |
dc.title | Use of antibiotics in bronchiectasis. | en |
dc.type | Review | en |
dc.type.studyortrial | Review article (e.g. literature review, narrative review) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.2174/157488712799363280 | en |
dc.publisher.place | Netherlands | en |
dc.identifier.pubmedid | 22023177 [http://www.ncbi.nlm.nih.gov/pubmed/?term=22023177] | en |
dc.identifier.source | 364311359 | en |
dc.identifier.institution | (King, Holmes) Department of Respiratory/Sleep Medicine, Monash Medical Centre Clayton, 246 Clayton Rd, Clayton, Melbourne 3168, Australia (King) Monash University, Department of Medicine, Monash Medical Centre, Melbourne, Australia | en |
dc.description.address | P. T. King, Department of Respiratory/Sleep Medicine, Monash Medical Centre Clayton, 246 Clayton Rd, Clayton, Melbourne 3168, Australia. E-mail: paul.king@monash.edu.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2013 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Antibiotic Resistance Bronchiectasis Inhalational Lung Macrolide | en |
dc.identifier.authoremail | King P.T.; paul.king@monash.edu.au | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Review | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.